Open AccessCOVID-19 Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A New Pediatric Alert
Author(s) -
Shamima Sharmin Shova,
Mohammad Imnul Islam
Publication year - 2021
Publication title -
journal of bangladesh college of physicians and surgeons/journal of bangladesh college of physicians and surgeons
Language(s) - English
Resource type - Journals
eISSN - 2309-6365
pISSN - 1015-0870
DOI - 10.3329/jbcps.v39i4.55946
Subject(s) - medicine , kawasaki disease , shock (circulatory) , disease , toxic shock syndrome , covid-19 , intensive care medicine , pathogenesis , pediatrics , immunology , infectious disease (medical specialty) , artery , biology , bacteria , genetics , staphylococcus aureus
Multisystem inflammatory syndrome in children (MIS-C), also termed pediatric multisystem inflammatory syndrome (PMIS) temporally associated with coronavirus disease-2019 (COVID-19) is rare but an emerging alarming condition. Though the exact pathogenesis is unknown, COVID-19 can trigger the condition directly or indirectly via immune complex mediated or antibody-dependent enhancement. Patients with MIS-C can present with persistent fever and a constellation of symptoms including hypotension, multiorgan involvement and elevated inflammatory markers. Presentations of MIS-C have overlapping features of Kawasaki disease (KD), toxic shock syndrome (TSS) and Kawasaki disease shock syndrome. Age of presentation, features of shock and more predilections for myocardial dysfunction can distinguish MIS-C from Kawasaki disease. Early recognition is essential, followed by prompt admission to the hospital for specialist attention. Admission to a pediatric intensive unit is mandatory for children with hemodynamic instability (shock, arrhythmia), significant respiratory compromise, or other potentially life-threatening complications. It is also necessary to maintain an appropriate follow-up schedule to observe the long-term outcome. The prognosis of PMIS/ MIS-C is uncertain, given that it is a new clinical entity and understanding of the disease is still evolving.J Bangladesh Coll Phys Surg 2021; 39: 249-260